S3870 HCPCS Level II code: Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability
S3870 is the HCPCS code for “Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
S3870Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability
Short description: Cgh test developmental delay
HCPCS · United States
Medicare details
The indicators CMS publishes with S3870 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Added
- Apr 1, 2009
Where S3870 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Active code S3870Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code S3870 mean?
S3870 is the HCPCS code for “Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover S3870?
CMS lists S3870’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S3870
All S codesS3853Genetic testing for myotonic muscular dystrophyS3854Gene expression profiling panel for use in the management of breast cancer treatmentS3855Genetic testing for detection of mutations in the presenilin - 1 geneS3861Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndromeS3865Comprehensive gene sequence analysis for hypertrophic cardiomyopathyS3866Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the familyS3890Dna analysis, fecal, for colorectal cancer screeningS3900Surface electromyography (emg)S3902BallistocardiogramS3904Masters two stepS4005Interim labor facility global (labor occurring but not resulting in delivery)S4011In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent…